Results 201 to 210 of about 22,259 (250)
Some of the next articles are maybe not open access.

Treatment of hepatocarcinoma

Current Oncology Reports, 2004
This article reviews the current developments and significant trends in the treatment of hepatocarcinoma (HCC). Prevention programs should be based on large vaccination campaigns and the use of immunologic or biologic molecules to delay the onset of HCC in already cirrhotic patients.
Gerard, Béatrice, Bleiberg, Harry
openaire   +3 more sources

Methylthioadenosine Phosphorylase Gene Expression Is Impaired in Human Liver Cirrhosis and Hepatocarcinoma [PDF]

open access: yesBiochimica Et Biophysica Acta - Molecular Basis of Disease, 2004
Methylthioadenosine phosphorylase (MTAP) is a key enzyme in the methionine and adenine salvage pathways. In mammals, the liver plays a central role in methionine metabolism, and this essential function is lost in the progression from liver cirrhosis to ...
Matias Avila   +2 more
exaly   +3 more sources

Liver transplantation for hepatocarcinoma

Surgery Today, 1993
A total of 592 patients underwent orthotopic liver transplantation in the Cambridge/King's College Hospital series (January 1980 to May 1991). A total of 89 (15%) patients had either primary or secondary hepatobiliary malignancies. Of these, 66 were hepatocellular carcinoma (HCC) and 13 were cholangiocarcinoma.
R, Calne   +3 more
openaire   +2 more sources

Ultrasonic Echogram in Differential Diagnosis of Primary Hepatocarcinoma and Metastatic Hepatocarcinoma

Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1992
The study on the differential diagnosis in 47 cases of primary hepatocarcinoma (PH) and 36 cases of metastatic hepatocarcinoma (MH) was performed with the real time B mode ultrasonic scanner. The pathological identifica­tions had been made before the ultrasonic scanning. The ultrasonic features seen in PH and MH were as follows: 1, Sound halo was found
Gu De Zhi, Zuo Lin, Zhang Li Ping
openaire   +1 more source

Non-surgical treatment of hepatocarcinoma

Journal of Surgical Oncology, 1993
Hepatocellular carcinoma (HCC) is one of the most common tumors affecting man. It is the general feeling that only hepatectomy can give a chance for cure. However, less than 20% of patients can be resected, and other treatment modalities are required.
Ravoet, Christophe   +2 more
openaire   +3 more sources

Hepatocarcinoma in Association with the Alagille Syndrome

Clinical Nuclear Medicine, 1988
An unusual image pattern of hepatocyte function in a 31-year-old man with the Alagille syndrome is presented. The Alagille syndrome is comprised of a constellation of findings, including characteristic facies, vertebral anomalies, retarded physical and sexual development, ocular posterior embryotoxon, peripheral pulmonary artery stenosis and ...
R P, duCret   +4 more
openaire   +2 more sources

Skin Metastasis From Hepatocarcinoma

The American Journal of Dermatopathology, 2009
Cutaneous metastases may be the first sign of an internal neoplasm; hepatocellular carcinoma is a very rare source of skin involvement and presents with a protean morphology: papules, nodules, and masses that may be by natural sources or by artificial mechanisms.
Mario, Magaña, Luz-Maria, Gomez
openaire   +2 more sources

Hepatocarcinoma in cirrhosis

Digestive Diseases and Sciences, 1991
It has been reported that hepatoma (HCC) cells produce abnormal proteins such as erytropietin, fibrinogen, prothrombin, and, recently, antithrombin III (AT III). In a preliminary report, we reported increased AT III levels in patients bearing HCC independent of their clinical liver status.
A, Grieco   +7 more
openaire   +2 more sources

Hepatocarcinoma: genetic and epigenetic features

Minerva Gastroenterology, 2017
HCC is the third leading cause of cancer-related deaths worldwide, accounting for about 1 million deaths annually. The incidence of HCC is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly predisposes to the development of chronic liver disease and subsequent development of HCC.
Lombardi, Angela   +4 more
openaire   +2 more sources

A Case of Cerebral Gigantism and Hepatocarcinoma

Archives of Pediatrics & Adolescent Medicine, 1977
A 14-year-old boy, who had the physical and neurological characteristics of cerebral gigantism (Sotos syndrome), developed hepatocarcinoma. This tumor is rare in children and has never, to our knowledge, been recorded in a patient with cerebral gigantism.
G I, Sugarman, E T, Heuser, W B, Reed
openaire   +2 more sources

Home - About - Disclaimer - Privacy